Hmmm... far from convinced. I'm not too sure it's good to be manipulating the glutamatergic system in the brain. Time will tell. If I had to make a wild guess based on my (admitedly fairly limited) knowledge of neuropharmacology at this point, though, I'd say they're going to induce some seizures in unsuspecting folks when they get into their expanded trials.
Just a guess at this point. Could be wrong. We'll see.
-TT